Literature DB >> 28774797

Mesenchymal stroma: Role in osteosarcoma progression.

Margherita Cortini1, Sofia Avnet2, Nicola Baldini3.   

Abstract

The initiation and progression of malignant tumors are supported by their microenvironment: cancer cells per se cannot explain growth and formation of the primary or metastasis, and a combination of proliferating tumor cells, cancer stem cells, immune cells mesenchymal stromal cells and/or cancer-associated fibroblasts all contribute to the tumor bulk. The interaction between these multiple players, under different microenvironmental conditions of biochemical and physical stimuli (i.e. oxygen tension, pH, matrix mechanics), regulates the production and biological activity of several soluble factors, extracellular matrix components, and extracellular vesicles that are needed for growth, maintenance, chemoresistance and metastatization of cancer. In osteosarcoma, a very aggressive cancer of young adults characterized by the extensive need for more effective therapies, this aspect has been only recently explored. In this view, we will discuss the role of stroma, with a particular focus on the mesenchymal stroma, contributing to osteosarcoma progression through inherent features for homing, neovascularization, paracrine cross-feeding, microvesicle secretion, and immune modulation, and also by responding to the changes of the microenvironment that are induced by tumor cells. The most recent advances in the molecular cues triggered by cytokines, soluble factors, and metabolites that are partially beginning to unravel the axis between stromal elements of mesenchymal origin and osteosarcoma cells, will be reviewed providing insights likely to be used for novel therapeutic approaches against sarcomas.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Extracellular vesicles; IL-6; Mesenchymal stroma; Metabolites; Microenvironment; Osteosarcoma

Mesh:

Substances:

Year:  2017        PMID: 28774797     DOI: 10.1016/j.canlet.2017.07.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  53 in total

1.  TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.

Authors:  Hitoshi Itoh; Tsuyoshi Kadomatsu; Hironori Tanoue; Masaki Yugami; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Eisuke Kobayashi; Takeshi Miyamoto; Ryoma Kurahashi; Kazutoyo Terada; Hiroshi Mizuta; Yuichi Oike
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

2.  MiR-1281, a p53-responsive microRNA, impairs the survival of human osteosarcoma cells upon ER stress via targeting USP39.

Authors:  Jian Jiang; Binbin Ma; Xiaojie Li; Wenlong Jin; Chuanchun Han; Ling Wang; Hong Wang
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

3.  SNHG15, a p53-regulated lncRNA, suppresses cisplatin-induced apoptosis and ROS accumulation through the miR-335-3p/ZNF32 axis.

Authors:  Yue-Feng Sun; Yuan Wang; Xiao-Dong Li; Hong Wang
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 4.  Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications.

Authors:  Huali Ye; Xin Hu; Yang Wen; Chongqi Tu; Francis Hornicek; Zhenfeng Duan; Li Min
Journal:  J Nanobiotechnology       Date:  2022-09-05       Impact factor: 9.429

5.  CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma.

Authors:  Qian Ran; Feng Jin; Yang Xiang; Lixin Xiang; Qiushi Wang; Fengjie Li; Li Chen; Yuan Zhang; Chun Wu; Luping Zhou; Yanni Xiao; Lili Chen; Jiang Wu; Jiang F Zhong; Shengwen Calvin Li; Zhongjun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 6.  Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.

Authors:  Eva C González Díaz; Sauradeep Sinha; Raffi S Avedian; Fan Yang
Journal:  Acta Biomater       Date:  2019-08-13       Impact factor: 8.947

7.  Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.

Authors:  Luciana M Gutiérrez; Matías Valenzuela Alvarez; Yuanzheng Yang; Fiorella Spinelli; María José Cantero; Laura Alaniz; Mariana G García; Eugenie S Kleinerman; Alejandro Correa; Marcela F Bolontrade
Journal:  Apoptosis       Date:  2021-05-22       Impact factor: 4.677

8.  Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.

Authors:  Wei-Jiang Zhao; Guan-Yong Ou; Wen-Wen Lin
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

9.  Curcumin-Loaded Nanoparticles Impair the Pro-Tumor Activity of Acid-Stressed MSC in an In Vitro Model of Osteosarcoma.

Authors:  Gemma Di Pompo; Margherita Cortini; Roberto Palomba; Valentina Di Francesco; Elena Bellotti; Paolo Decuzzi; Nicola Baldini; Sofia Avnet
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

10.  Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma.

Authors:  Yi He; Haiting Zhou; Wei Wang; Haoran Xu; Hao Cheng
Journal:  Front Genet       Date:  2021-05-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.